Tags

Type your tag names separated by a space and hit enter

[Probiotics in chronic inflammatory bowel disease].
MMW Fortschr Med. 2006 Aug 31; 148(35-36):30-4.MF

Abstract

Current data show that probiotics are more effective in preventing the recrudescence of an inflammatory process than in suppressing active disease. This is reflected in the solid evidence for the effect of E. coli Nissle 1917 (Mutaflor) in the maintenance of remission of ulcerative colitis, and of VSL#3 in preventing the recurrence of pouchitis. These indications have since been incorporated in valid guidelines. Initial clinical studies have also provided promising results regarding the efficacy of VSL#3 in preventing pouchitis immediately following proctocolectomy.

Authors+Show Affiliations

Evangelisches Krankenhaus Kalk, Köln. boehm@evkk.deNo affiliation info available

Pub Type(s)

Comparative Study
English Abstract
Journal Article
Review

Language

ger

PubMed ID

16995360

Citation

Böhm, S, and W Kruis. "[Probiotics in Chronic Inflammatory Bowel Disease]." MMW Fortschritte Der Medizin, vol. 148, no. 35-36, 2006, pp. 30-4.
Böhm S, Kruis W. [Probiotics in chronic inflammatory bowel disease]. MMW Fortschr Med. 2006;148(35-36):30-4.
Böhm, S., & Kruis, W. (2006). [Probiotics in chronic inflammatory bowel disease]. MMW Fortschritte Der Medizin, 148(35-36), 30-4.
Böhm S, Kruis W. [Probiotics in Chronic Inflammatory Bowel Disease]. MMW Fortschr Med. 2006 Aug 31;148(35-36):30-4. PubMed PMID: 16995360.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Probiotics in chronic inflammatory bowel disease]. AU - Böhm,S, AU - Kruis,W, PY - 2006/9/26/pubmed PY - 2006/11/14/medline PY - 2006/9/26/entrez SP - 30 EP - 4 JF - MMW Fortschritte der Medizin JO - MMW Fortschr Med VL - 148 IS - 35-36 N2 - Current data show that probiotics are more effective in preventing the recrudescence of an inflammatory process than in suppressing active disease. This is reflected in the solid evidence for the effect of E. coli Nissle 1917 (Mutaflor) in the maintenance of remission of ulcerative colitis, and of VSL#3 in preventing the recurrence of pouchitis. These indications have since been incorporated in valid guidelines. Initial clinical studies have also provided promising results regarding the efficacy of VSL#3 in preventing pouchitis immediately following proctocolectomy. SN - 1438-3276 UR - https://www.unboundmedicine.com/medline/citation/16995360/[Probiotics_in_chronic_inflammatory_bowel_disease]_ L2 - https://medlineplus.gov/crohnsdisease.html DB - PRIME DP - Unbound Medicine ER -